The Hospital Readmissions Reduction Program and Readmissions for Chronic Obstructive Pulmonary Disease, 2006–2015-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

The Hospital Readmissions Reduction Program and Readmissions for Chronic Obstructive Pulmonary Disease, 2006–2015

Published:2020-04 Issue:4 Volume:17 Page:450-456
ISSN:2329-6933
Container-title:Annals of the American Thoracic Society
language:en
Short-container-title:Annals ATS

Author:

Myers Laura C.¹^ORCID,Faridi Mohammad K.²,Hasegawa Kohei²,Hanania Nicola A.³,Camargo Carlos A.²

Affiliation:

1. Division of Pulmonary/Critical Care, Department of Medicine, and

2. Department of Emergency Medicine, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts; and

3. Section of Pulmonary, Critical Care, and Sleep Medicine, Baylor College of Medicine, Houston, Texas

Publisher

American Thoracic Society

Subject

Pulmonary and Respiratory Medicine

Reference31 articles.

1. Hospital Discharges, Readmissions, and ED Visits for COPD or Bronchiectasis Among US Adults

2. Acute Exacerbations of COPD in the United States: Inpatient Burden and Predictors of Costs and Mortality

3. Understanding Why Patients With COPD Get Readmitted

4. Time-varying Readmission Diagnoses During 30 Days After Hospitalization for COPD Exacerbation

5. Incidence of potentially avoidable urgent readmissions and their relation to all-cause urgent readmissions

Cited by 23 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Predictors of Readmission, for Patients with Chronic Obstructive Pulmonary Disease (COPD) – A Systematic Review;International Journal of Chronic Obstructive Pulmonary Disease;2023-11

2. Acute exacerbation of chronic obstructive pulmonary disease in United States emergency departments, 2010–2018;BMC Pulmonary Medicine;2023-06-20

3. All-Cause 30-Day Readmission and Mortality;JONA: The Journal of Nursing Administration;2023-04

4. All-cause readmission rate and risk factors of 30- and 90-day after discharge in patients with chronic obstructive pulmonary disease: a systematic review and meta-analysis;Therapeutic Advances in Respiratory Disease;2023-01

5. Care Quality for Patients with Chronic Obstructive Pulmonary Disease in the Readmission Penalty Era;American Journal of Respiratory and Critical Care Medicine;2023-01-01

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3